Prenatal Methamphetamine Exposure and Short-Term Maternal and Infant Medical Outcomes

Rizwan Shah; Sabrina D. Diaz; Amelia Arria; Linda L. LaGasse; Chris Derauf; Elana Newman; Lynne M. Smith; Marilyn A. Huestis; William Haning; Arthur Strauss; Sheri Della Grotta; Lynne M. Dansereau; Mary B. Roberts; Charles Neal; Barry M. Lester

doi:10.1055/s-0032-1304818

American Journal of Perinatology, Inhaltsverzeichnis

Am J Perinatol 2012; 29(05): 391-400
DOI: 10.1055/s-0032-1304818

Original Article

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Prenatal Methamphetamine Exposure and Short-Term Maternal and Infant Medical Outcomes

Autor*innen

Rizwan Shah

¹Blank Hospital Regional Child Protection Center, Iowa Health, Des Moines, Iowa
Sabrina D. Diaz

²LABiomed Institute at Harbor–UCLA Medical Center and David Geffen School of Medicine at UCLA, Los Angeles, California
Amelia Arria

³Center on Young Adult Health and Development, University of Maryland, School of Public Health, College Park, Maryland
Linda L. LaGasse

⁴Brown Center for the Study of Children at Risk, Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, Rhode Island
Chris Derauf

⁵John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii
Elana Newman

⁶Department of Psychology, The University of Tulsa, Tulsa, Oklahoma
Lynne M. Smith

²LABiomed Institute at Harbor–UCLA Medical Center and David Geffen School of Medicine at UCLA, Los Angeles, California
Marilyn A. Huestis

⁷Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, Maryland
William Haning

⁵John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii
Arthur Strauss

⁸Miller Children's Hospital at Long Beach Memorial Medical Center, Long Beach, California
Sheri Della Grotta

⁴Brown Center for the Study of Children at Risk, Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, Rhode Island
Lynne M. Dansereau

⁴Brown Center for the Study of Children at Risk, Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, Rhode Island
Mary B. Roberts

⁴Brown Center for the Study of Children at Risk, Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, Rhode Island
Charles Neal

⁵John A. Burns School of Medicine, University of Hawaii, Honolulu, Hawaii
Barry M. Lester

⁴Brown Center for the Study of Children at Risk, Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, Rhode Island

Abstract

Objective Examine maternal and infant medical outcomes of prenatal exposure to methamphetamine (MA).

Study Design Four hundred and twelve mother-infant pairs (204 MA-exposed and 208 unexposed matched comparisons) were enrolled in the Infant Development, Environment and Lifestyle (IDEAL) study. Exposure was determined by maternal self-report during this pregnancy and/or positive meconium toxicology. Maternal interviews assessed prenatal drug use, pregnancy course, and sociodemographic information. Medical chart reviews provided medical history, obstetric complications, infant outcomes, and discharge placement.

Results MA-using mothers were more likely to be poor, to have a psychiatric disorder/emotional illness and less prenatal care, and to be less likely to breast-feed their infant than comparison mothers. After adjusting for covariates, MA-exposed infants were more likely to exhibit poor suck, to have smaller head circumferences and length, to require neonatal intensive care unit (NICU) admission, and to be referred to child protective services (CPS). Several outcomes previously reported from studies that lacked adequate control groups or adjustment for covariates were not significantly different in this study.

Conclusion Prenatal MA exposure is associated with maternal psychiatric disorder/emotional illness, poor suck, NICU admission, and CPS involvement, and MA-exposed infants were less likely to be breast-fed; however, the absence of many serious complications, such as fetal distress, chronic hypertension, preeclampsia, placenta previa, abruptio placentae, and cardiac defects, suggests confounding variables influenced prior studies.

Keywords

amphetamine - methamphetamine - drug - antenatal - neonate

Volltext

Referenzen

References
1 Substance Abuse and Mental Health Services Administration. Results from the 2007 National Survey on Drug Use and Health: National Findings. NSDUH Series: 2008 H-34
2 Kuczkowski KM. The effects of drug abuse on pregnancy. Curr Opin Obstet Gynecol 2007; 19: 578-585
3 Plessinger MA. Prenatal exposure to amphetamines. Risks and adverse outcomes in pregnancy. Obstet Gynecol Clin North Am 1998; 25: 119-138
4 Bartu A, Dusci LJ, Ilett KF. Transfer of methylamphetamine and amphetamine into breast milk following recreational use of methylamphetamine. Br J Clin Pharmacol 2009; 67: 455-459
5 Ganapathy VV, Prasad PD, Ganapathy ME, Leibach FH. Drugs of abuse and placental transport. Adv Drug Deliv Rev 1999; 38: 99-110
6 Good MM, Solt I, Acuna JG, Rotmensch S, Kim MJ. Methamphetamine use during pregnancy: maternal and neonatal implications. Obstet Gynecol 2010; 116 (2 Pt 1) 330-334
7 Eriksson M, Larsson G, Winbladh B, Zetterström R. The influence of amphetamine addiction on pregnancy and the newborn infant. Acta Paediatr Scand 1978; 67: 95-99
8 Eriksson M, Larsson G, Zetterström R. Amphetamine addiction and pregnancy. II. Pregnancy, delivery and the neonatal period. Socio-medical aspects. Acta Obstet Gynecol Scand 1981; 60: 253-259
9 Oro AS, Dixon SD. Perinatal cocaine and methamphetamine exposure: maternal and neonatal correlates. J Pediatr 1987; 111: 571-578
10 Elliott RH, Rees GB. Amphetamine ingestion presenting as eclampsia. Can J Anaesth 1990; 37: 130-133
11 Samuels SI, Maze A, Albright G. Cardiac arrest during cesarean section in a chronic amphetamine abuser. Anesth Analg 1979; 58: 528-530
12 Smith L, Yonekura ML, Wallace T, Berman N, Kuo J, Berkowitz C. Effects of prenatal methamphetamine exposure on fetal growth and drug withdrawal symptoms in infants born at term. J Dev Behav Pediatr 2003; 24: 17-23
13 Little BB, Snell LM, Gilstrap III LC. Methamphetamine abuse during pregnancy: outcome and fetal effects. Obstet Gynecol 1988; 72: 541-544
14 Oei J, Abdel-Latif ME, Clark R, Craig F, Lui K. Short-term outcomes of mothers and infants exposed to antenatal amphetamines. Arch Dis Child Fetal Neonatal Ed 2010; 95: F36-F41
15 McElhatton PR, Pughe KR, Evans C, Porter K, Bateman DN, Thomas SH. Is exposure to amphetamine-like drugs in pregnancy associated with malformations?. J Toxicol Clin Toxicol 2000; 38: 195-196
16 Torfs CP, Velie EM, Oechsli FW, Bateson TF, Curry CJ. A population-based study of gastroschisis: demographic, pregnancy, and lifestyle risk factors. Teratology 1994; 50: 44-53
17 Derauf C, LaGasse LL, Smith LM , et al. Demographic and psychosocial characteristics of mothers using methamphetamine during pregnancy: preliminary results of the infant development, environment, and lifestyle study (IDEAL). Am J Drug Alcohol Abuse 2007; 33: 281-289
18 Smith LM, Lagasse LL, Derauf C , et al. Prenatal methamphetamine use and neonatal neurobehavioral outcome. Neurotoxicol Teratol 2008; 30: 20-28
19 Nguyen D, Smith LM, Lagasse LL , et al. Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. J Pediatr 2010; 157: 337-339
20 Smith LM, LaGasse LL, Derauf C , et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 2006; 118: 1149-1156
21 Bauer CR, Shankaran S, Bada HS , et al. The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol 2002; 186: 487-495
22 Lester BM, Tronick EZ, LaGasse L , et al. The maternal lifestyle study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 2002; 110: 1182-1192
23 Della Grotta S, LaGasse LL, Arria AM , et al. Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Matern Child Health J 2010; 14: 519-527
24 Richardson GA, Hamel SC, Goldschmidt L, Day NL. Growth of infants prenatally exposed to cocaine/crack: comparison of a prenatal care and a no prenatal care sample. Pediatrics 1999; 104: e18
25 Shankaran S, Das A, Bauer CR , et al. Association between patterns of maternal substance use and infant birth weight, length, and head circumference. Pediatrics 2004; 114: e226-e234
26 Hollingshead AB. Four factor index of social status. New Haven, CT: Department of Sociology, Yale University; 1975
27 Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol 1996; 87: 163-168
28 Benningfield MM, Arria AM, Kaltenbach K , et al. Co-occurring psychiatric symptoms are associated with increased psychological, social, and medical impairment in opioid dependent pregnant women. Am J Addict 2010; 19: 416-421
29 Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction 2009; 104: 1085-1099
30 Marshall BD, Werb D. Health outcomes associated with methamphetamine use among young people: a systematic review. Addiction 2010; 105: 991-1002
31 Zweben JE, Cohen JB, Christian D , et al; Methamphetamine Treatment Project. Psychiatric symptoms in methamphetamine users. Am J Addict 2004; 13: 181-190
32 Glasner-Edwards S, Mooney LJ, Marinelli-Casey P, Hillhouse M, Ang A, Rawson RA ; Methamphetamine Treatment Project Corporate Authors. Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug Alcohol Rev 2010; 29: 12-20
33 Terplan M, Smith EJ, Kozloski MJ, Pollack HA. Methamphetamine use among pregnant women. Obstet Gynecol 2009; 113: 1285-1291
34 Catanzarite VA, Stein DA. “Crystal” and pregnancy—methamphetamine-associated maternal deaths. West J Med 1995; 162: 454-457
35 Nordstrom-Klee B, Delaney-Black V, Covington C, Ager J, Sokol R. Growth from birth onwards of children prenatally exposed to drugs: a literature review. Neurotoxicol Teratol 2002; 24: 481-488
36 Hall W, Hando J. Route of administration and adverse effects of amphetamine use among young adults in Syndney, Australia. Drug Alcohol Rev 1994; 13: 277-284
37 Ujike H, Sato M. Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Ann N Y Acad Sci 2004; 1025: 279-287